Coherus BioSciences Inc (CHRS) — Free Cash Flow Generation Index
Coherus BioSciences Inc (CHRS) has a Free Cash Flow Generation Index of 1.00x as of December 2024. Free cash flow of $28.61 Million represents 1% of operating cash flow ($28.61 Million). See CHRS current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Coherus BioSciences Inc Free Cash Flow Generation Index (2013–2020)
Historical FCF Generation Index trend for Coherus BioSciences Inc across 3 annual periods. Explore CHRS debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Coherus BioSciences Inc (2013–2020)
Year-by-year Free Cash Flow Generation Index for Coherus BioSciences Inc. For the full company profile including market capitalisation, see Coherus BioSciences Inc market cap and net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.95x | $146.91 Million | $154.15 Million | $7.23 Million | ▲ +74.8% |
| 2019 | 0.55x | $15.46 Million | $28.36 Million | $12.90 Million | ▼ -44.1% |
| 2013 | 0.98x | $15.05 Million | $15.42 Million | $373.00K | — |